Inactive Instrument
LungLife AI, Inc. Stock
Stocks
LLAI
USU5500L1045
Biotechnology & Medical Research
| 1 day | -2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 42 | - |
David Anderson
DFI | Director of Finance/CFO | 63 | - |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sara Barrington
BRD | Director/Board Member | 59 | 08/07/2021 |
David Anderson
BRD | Director/Board Member | 63 | 08/07/2021 |
Paul Pagano
BRD | Director/Board Member | 42 | 15/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/10/24 | Free | Chief Executive Officer | 769,707 | 3.0201% | ||
| 04/10/24 | Free | Chief Financial Officer | 386,703 | 1.5173% | ||
| 14/08/23 | Buy | Chief Executive Officer | 12,123 | 0.0476% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.35% | +18.57% | - | - | 1.7M | ||
| -2.49% | -6.35% | +51.07% | +64.95% | 65.42B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.91B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 55.24B | ||
| -0.88% | -4.85% | +13.46% | +110.94% | 45.66B | ||
| -0.80% | -6.10% | +14.66% | +21.27% | 41.29B | ||
| -0.93% | +1.67% | +20.83% | +45.03% | 36.82B | ||
| +1.11% | -6.20% | +131.27% | +643.72% | 34.48B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.5B | ||
| +1.07% | +20.60% | -26.81% | +493.50% | 31.69B | ||
| Average | -0.87% | -0.66% | +34.54% | +178.58% | 45B | |
| Weighted average by Cap. | -0.93% | -1.28% | +32.70% | +152.53% |
Employees
8
















